-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS INC: COMBINATION OF SEMAGLUTIDE WITH TREVOGRUMAB WAS GENERALLY WELL-TOLERATED

Reuters·06/02/2025 11:00:01

Please log in to view news